|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.39 CNY | +2.11% |
|
+4.31% | -36.64% |
Shanghai Xuerong Biotechnology Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 973.54 million compared to CNY 928.81 million a year ago. Net loss was CNY 100.81 million compared to CNY 70.7 million a year ago.
Basic loss per share from continuing operations was CNY 0.21 compared to CNY 0.16 a year ago. Diluted loss per share from continuing operations was CNY 0.19 compared to CNY 0.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.64% | 229M | |
| +17.55% | 1.01B | |
| +13.68% | 796M | |
| 0.00% | 780M | |
| -26.74% | 658M | |
| -8.75% | 381M | |
| +4.90% | 372M | |
| -30.72% | 275M | |
| -7.25% | 272M | |
| +4.39% | 255M |
SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD. 
